Nifurtimox + eflornithine (Inclusion)
Drug information
Drug name: Nifurtimox + eflornithine
Section 6.5.5: Antitrypanosomal medicines
Formulation:
Nifurtimox (oral tablets): 15 mg/kg/day (5 mg/kg every 8 hours) for 10 days
Plus
Eflornithine (slow iv infusion): 400 mg/kg/day (200 mg/kg every 12 hours) for 7 days
Application prepared by:
Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
-
Application for inclusion
pdf, 1.17Mb -
Presentation: Multicenter clinical trial of nifurtimox-eflornithine combination therapy for second-stage sleeping sickness
pdf, 947kb -
Letter of support from the Institute of Tropical Medicine, Belgium
pdf, 91kb -
Letter of support received from Chairperson, EANETT Board of Management
pdf, 82kb - EXPERT REVIEWS
-
Letter of support from the Swiss Tropical Institute
pdf, 96kb -
Support from MSF
pdf, 17kb -
Letter of support from DR Congo authorities
pdf, 105kb -
Support from Director, WHO Collaborating Center for African Trypanosomiasis Treatment Failure
pdf, 52kb -
Comments from Director, NTD
pdf, 69kb -
Comments from UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization
pdf, 13kb